Search


	Podcast:		BioCentury This Week
	Episode:		Ep. 212 - 2024 Buyside View & Arnold Ventures' Impact
	Category:		Science & Medicine
	Duration:		00:30:09
	Publish Date:		2024-01-23 01:00:00
	Description:		Biotech investors are looking to catalysts that can create, or dramatically expand, commercial markets as they look ahead to a long-awaited recovery for industry. On the latest BioCentury This Week podcast, BioCentury’s editors assess the milestones on buysiders’ radar for 2024, including in areas such as obesity, pain and metabolic-associated steatohepatitis (MASH). They also discuss the influence of biopharma critic Arnold Ventures, a philanthropy that has reshaped the drug pricing public policy landscape; lung cancer data for Gilead's Trodelvy; and the week's expected biotech IPOs. Music for The East-West Biopharma Summit: Singapore teaser produced by: Moa Michaeli, Samuel Aneheim Ulvenäs, Albin Lewin, Epidemic Sound via Getty Images
	Total Play:		0